Benefits of Bacillus coagulans as a probiotic
Clinical studies have revealed that L. sporogenes* can be successfully implanted in the intestine. As explained in an earlier section, L. sporogenes* satisfies the essential requirements of an efficient probiotic. Preparations of L. sporogenes* in pharmaceutical dosage forms such as tablets, capsules, dried granules or powder have the following characteristics:
- Contain a large number of viable lactobacilli that retain viability during preparation in pharmaceutical dosage forms and during storage before consumption. The spores are thermostable as against viable L. acidophilus cells which may not withstand spray drying.
- Survive in gastric secretions and bile of the upper digestive tract and reach the intestine safely.
- Settle in the digestive tract and produce enough lactic acid and other antagonistic substances to inhibit the growth of pathogenic bacteria.
Being sporulated, they germinate under favorable conditions and produce sufficient viable cells which proliferate and perform vital healthful functions as described earlier. In addition, L. sporogenes* spores are semi-resident and are slowly excreted out of the body (7 days after discontinuation of administration).
The taxonomical classification was revised in 1939 in the seventh edition of the Bergey’s Manual of Determinative Bacteriology to B. coagulans, although some researchers continued to use the original name.